Current liabilities increased 35.1%
Current liabilities changed +35.1% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Current liabilities changed +35.1% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Operating margin changed +12184 basis points from the comparable as-filed period.
Operating income changed +61.4% from the comparable as-filed period.
Revenue changed +51.7% from the comparable as-filed period.
Net income changed +62.3% from the comparable as-filed period.
Gross margin changed +9050 basis points from the comparable as-filed period.
Trade receivables changed +53.1% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Operating cash flow changed +21.5% from the comparable as-filed period.
Inventory / revenue changed -10682 basis points from the comparable as-filed period.
Current ratio changed -25.3% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
Cost of revenue changed -65.2% from the comparable as-filed period.
Stock-based compensation changed +36.7% from the comparable as-filed period.
Free-cash-flow proxy changed +12.6% from the comparable as-filed period.
SBC / revenue changed -227 basis points from the comparable as-filed period.
R&D / revenue changed -930 basis points from the comparable as-filed period.
Operating cash-flow margin changed +648 basis points from the comparable as-filed period.
Free-cash-flow margin changed +770 basis points from the comparable as-filed period.
Research & development changed +16.9% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Working capital / assets changed -488 basis points from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
Cash & equivalents changed -15.2% from the comparable as-filed period.
Capex / revenue changed -122 basis points from the comparable as-filed period.
Working capital changed -8.0% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
Gross profit changed +733.5% from the comparable as-filed period. Relative percentage is de-emphasized because the comparison has a sign change.
Inventory changed -4.3% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Receivables / revenue changed +103 basis points from the comparable as-filed period.
Capital expenditure changed +12.7% from the comparable as-filed period.
Total assets changed -0.7% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
Current assets changed +0.9% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
Trade receivables changed +40.9% from the comparable as-filed period.
Current liabilities changed +31.2% from the comparable as-filed period.
Current ratio changed -28.5% from the comparable as-filed period.
Inventory changed -15.0% from the comparable as-filed period.
Working capital / assets changed -337 basis points from the comparable as-filed period.
Working capital changed -14.2% from the comparable as-filed period.
Total assets changed -9.7% from the comparable as-filed period.
Current assets changed -6.2% from the comparable as-filed period.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.